HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kenzo Pour Homme Revitalization To Strengthen Brand Recognition

This article was originally published in The Rose Sheet

Executive Summary

Givenchy will relaunch Kenzo Pour Homme men's fragrance in September as the first step in an entire brand repackaging initiative to modernize and streamline the image of the brand, the LVMH division said

You may also be interested in...



Kenzo Fragrance Repositioning Builds On Strength Of Flower

Givenchy is relaunching Kenzo Parfum d'Eté and Jungle Elephant fragrances in 2003 to better align them with Flower by Kenzo, the LVMH division said

Kenzo Fragrance Repositioning Builds On Strength Of Flower

Givenchy is relaunching Kenzo Parfum d'Eté and Jungle Elephant fragrances in 2003 to better align them with Flower by Kenzo, the LVMH division said

Parfums Givenchy

Kenzo Flower to launch in limited domestic distribution at Bloomingdale's in New York City and Nordstrom stores nationwide this fall. "Powdery, floral" fragrance is composed of three accords: "vibrant, floral" top note featuring wild hawthorn and parma violet, "feminine" secondary accord of vanilla and opopanax; and final note of hedione and cyclosal. Flower, which launched in Europe in 2000, will be available in 30 mL ($50), 50 mL ($60) and 100 mL ($80) sizes. Givenchy has hopes new scent, along with popular Michael by Michael Kors and forthcoming Marc Jacobs signature scents, will attain top ranking in their limited distribution this fall ("The Rose Sheet," May 7, p. 3)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel